122 related articles for article (PubMed ID: 9166527)
1. Practice guidelines for prostate cancer.
Ahlering T; Parker R; Kumar S; Taylor C; Gilden R; Figlin RA
Cancer J Sci Am; 1996; 2(3A Suppl):S77-86. PubMed ID: 9166527
[No Abstract] [Full Text] [Related]
2. Prostate cancer Tx. Therapeutic options based on tumor grade, life expectancy, and patient preferences.
Cohen SP; Jaskulsky SR
Geriatrics; 2001 Feb; 56(2):39, 42, 47-8 passim. PubMed ID: 11219024
[TBL] [Abstract][Full Text] [Related]
3. A critical review of clinical practice guidelines for the management of clinically localized prostate cancer.
Dahm P; Yeung LL; Chang SS; Cookson MS
J Urol; 2008 Aug; 180(2):451-9; discussion 460. PubMed ID: 18550100
[TBL] [Abstract][Full Text] [Related]
4. NCCN Practice Guidelines for Prostate Cancer.
Bahnson RR; Hanks GE; Huben RP; Kantoff P; Kozlowski JM; Kuettel M; Lange PH; Logothetis C; Pow-Sang JM; Roach M; Sandler H; Scardino PT; Taylor RJ; Urban DA; Walsh PC; Wilson TG;
Oncology (Williston Park); 2000 Nov; 14(11A):111-9. PubMed ID: 11195405
[TBL] [Abstract][Full Text] [Related]
5. Risk factors, prevention and early detection of prostate cancer.
Loeb S; Schaeffer EM
Prim Care; 2009 Sep; 36(3):603-21. PubMed ID: 19616157
[TBL] [Abstract][Full Text] [Related]
6. Editorial comment on: Insignificant prostate cancer and active surveillance: from definition to clinical implications.
Aus G
Eur Urol; 2009 Jun; 55(6):1331. PubMed ID: 19286303
[No Abstract] [Full Text] [Related]
7. [Cancer of the prostate. Diagnosis, prognosis, principles of treatment].
Lopez JG; Perrin P
Rev Prat; 1999 Feb; 49(3):297-301. PubMed ID: 10189800
[No Abstract] [Full Text] [Related]
8. High Intensity Focused Ultrasound (HIFU): a useful alternative choice in prostate cancer treatment. Preliminary results.
Maestroni U; Ziveri M; Azzolini N; Dinale F; Ziglioli F; Campaniello G; Frattini A; Ferretti S
Acta Biomed; 2008 Dec; 79(3):211-6. PubMed ID: 19260381
[TBL] [Abstract][Full Text] [Related]
9. A retrospective study of the treatment of locally advanced prostate cancer by six institutions in eastern and north-eastern Japan.
Hachiya T; Akakura K; Saito S; Shinohara N; Sato K; Harada M; Kato T; Okada K
BJU Int; 2005 Mar; 95(4):534-40. PubMed ID: 15705075
[TBL] [Abstract][Full Text] [Related]
10. EAU guidelines on prostate cancer.
Aus G; Abbou CC; Bolla M; Heidenreich A; Schmid HP; van Poppel H; Wolff J; Zattoni F;
Eur Urol; 2005 Oct; 48(4):546-51. PubMed ID: 16046052
[TBL] [Abstract][Full Text] [Related]
11. Association of chromosomal locus 8q24 and risk of prostate cancer: a hospital-based study of German patients treated with brachytherapy.
Meyer A; Schürmann P; Ghahremani M; Kocak E; Brinkhaus MJ; Bremer M; Karstens JH; Hagemann J; Machtens S; Dörk T
Urol Oncol; 2009; 27(4):373-6. PubMed ID: 18625567
[TBL] [Abstract][Full Text] [Related]
12. Prostate cancer diagnosis in the new millennium: strengths and weaknesses of prostate-specific antigen and the discovery and clinical evaluation of prostate cancer gene 3 (PCA3).
Kirby RS; Fitzpatrick JM; Irani J
BJU Int; 2009 Feb; 103(4):441-5. PubMed ID: 19154510
[TBL] [Abstract][Full Text] [Related]
13. Uncertainty and quality of life among men undergoing active surveillance for prostate cancer in the United States and Ireland.
Hegarty JM; Wallace M; Comber H
Am J Mens Health; 2008 Jun; 2(2):133-42. PubMed ID: 19477777
[TBL] [Abstract][Full Text] [Related]
14. [Characterisation of families with hereditary prostate cancer in the Netherlands].
Meulenbeld HJ; Verhage BA; Kil PJ; Kiemeney LA; Vasen HF
Ned Tijdschr Geneeskd; 2002 Oct; 146(41):1938-42. PubMed ID: 12404910
[TBL] [Abstract][Full Text] [Related]
15. Editorial comment on: Insignificant prostate cancer and active surveillance: from definition to clinical implications.
Albertson PC
Eur Urol; 2009 Jun; 55(6):1331-2. PubMed ID: 19286304
[No Abstract] [Full Text] [Related]
16. Sequence variants of Toll-like receptor 4 and susceptibility to prostate cancer.
Chen YC; Giovannucci E; Lazarus R; Kraft P; Ketkar S; Hunter DJ
Cancer Res; 2005 Dec; 65(24):11771-8. PubMed ID: 16357190
[TBL] [Abstract][Full Text] [Related]
17. Early prostate cancer diagnosis and therapy.
Glodé LM
Adv Intern Med; 2000; 45():41-64. PubMed ID: 10635045
[No Abstract] [Full Text] [Related]
18. The potentially curable prostate cancer patient and the pathways leading to diagnosis and treatment.
Gjengstø P; Eide J; Frugård J; Bakke A; Høisaeter PA
Scand J Urol Nephrol; 2004; 38(1):15-8. PubMed ID: 15204421
[TBL] [Abstract][Full Text] [Related]
19. The apolipoprotein E epsilon4 allele is no risk factor for prostate cancer in the Norwegian population.
Wessel N; Liestøl K; Maehlen J; Brorson SH
Br J Cancer; 2001 Nov; 85(9):1418. PubMed ID: 11720484
[No Abstract] [Full Text] [Related]
20. Oncology today: new horizons. Prostate cancer.
Greifzu SP
RN; 2000 Jun; 63(6):26-31; quiz 32. PubMed ID: 10897747
[No Abstract] [Full Text] [Related]
[Next] [New Search]
